š§ Olanzapine has built a reputation as a heavy-hitter for treating acute manic episodesābut the data tells a more modest story.
In one key study comparing olanzapine vs. placebo over 3 weeks:
- Response rate: 55% (olanzapine) vs. 30% (placebo)
- Remission rate: 18% (olanzapine) vs. 7% (placebo)
Thatās a 25% absolute difference in response and just an 11% difference in remissionānot exactly blockbuster results.
This doesnāt mean olanzapine has no role in mania treatment. But itās time to recalibrate our expectations and remain clear-eyed about what the data shows.
š Efficacy matters. So does the narrative we build around our tools.
